Alexander Schmitz

Alexander is a Partner at Endeavour Vision, focusing on medical technology, digital health, and diagnostics companies across multiple therapeutic areas.

He brings more than two decades of business and strategy experience in medical device and high-technology companies. He currently represents Endeavour Vision on the boards of Gynesonics, Kenbi, Lumeon and VentureMed, and co-led the firm’s investments in Nalu, Nuvaira and V-Wave. He previously served on the boards of Relievant MedSystems and VertiFlex (both acquired by Boston Scientific) and Rapid Micro Biosystems (NASDAQ:RPID). He is a member of the steering committee for PCR Innovators’ Day and has served as a jury member and expert panellist for the HealthTech Summit.

Prior to joining the Endeavour Vision team, Alexander spent nine years with Biosensors International Group, an interventional cardiology company, where he served as vice president of business development. He previously worked with LogiSpring Ventures, MicroStrategy and McKinsey & Co.

Alexander holds an MBA from INSEAD and a BSFS, magna cum laude, in economics from Georgetown University.